Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
Condition(s):Liver Cirrhosis; Hepatitis C Virus; HIV InfectionLast Updated:December 30, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Liver Cirrhosis; Hepatitis C Virus; HIV InfectionLast Updated:December 30, 2011Completed
Condition(s):Hepatitis CLast Updated:January 9, 2018Completed
Condition(s):Hepatitis C, ChronicLast Updated:July 22, 2013Completed
Condition(s):HCV Coinfection; HIV-1 InfectionLast Updated:October 13, 2014Completed
Condition(s):Chronic Hepatitis CLast Updated:May 15, 2012Completed
Condition(s):Hepatitis C, ChronicLast Updated:October 30, 2013Completed
Condition(s):Hepatitis C, ChronicLast Updated:April 12, 2017Completed
Condition(s):Hepatitis C Virus InfectionLast Updated:May 12, 2020Completed
Condition(s):Lassa FeverLast Updated:July 6, 2022Terminated
Condition(s):Hepatitis C, ChronicLast Updated:September 10, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.